MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

19 Dec 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Glenmark Pharmaceuticals receives ANDA approval for Nicardipine Hydrochloride Capsules, 20 mg and 30 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..